SEHK:673Healthcare
China Health Group (SEHK:673) Losses Deepen, Undercutting Bullish Value Narrative
China Health Group (SEHK:673) has released its H1 2026 financials, reporting revenue of HK$20.26 million and a basic EPS of -0.1027 HKD. Looking back, the company’s revenue was HK$18.68 million in H1 2025 and HK$31.66 million in H2 2024. Basic EPS figures were -0.0359 HKD and -0.0525 HKD for these periods. Persistently negative earnings reflect margins under pressure, raising ongoing concerns about the company’s ability to achieve profitability.
See our full analysis for China Health...